Answer
The selected product treats mild to moderate type 1 Gaucher disease in adults when enzyme replacement therapy is unsuitable, and progressive neurological manifestations of Niemann–Pick type C disease in adults and children.
Sources for this answer
- Yargesa (miglustat) 100mg Hard Capsulesemc · SmPC Current selected SmPC · Version 6